Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be able to provide their written informed consent to participate in the study after having received adequate previous information and prior to any study specific procedures.~* At least 18 years of age at the time of screening.~* Patients with PH secondary to left heart disease (known as group II PH) defined as a mean PAP\>25 mmHg and a PCWP of ≥15 mmHg.~Exclusion Criteria:~* All other types of pulmonary hypertension including Dana Point Classification Group 1, 3, 5.~* Type II Diabetes mellitus requiring medical therapy~* Previous myocardial infarction within the 3 months prior to screening.~* Renal insufficiency (glomerular filtration rate \< 30 ml/min.~* ALT or AST \> 3times ULN and/or severe hepatic insufficiency.~* Contraindication to MRI imaging.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FDG PET scan (Type: EXPERIMENTAL): A PET scan using F-18 FDG, N-13 Ammonia will be performed

Based on this trial design, predict the completion outcome and termination type (if applicable).